Total number of projects: 3
As coordinator: 1
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0.5*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2021 | 6.900.000 | 0 | 5.094.401 | 1 | ||
2019 | 0 | 14.931.338 | 5.229.000 | 1 | ||
2017 | 0 | 6.685.111 | 969.375 | 1 |
Total number of partners: 31
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 31
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2021-02-01 | Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine | TIGER | coordinator | 6.900.000 | 8 |
2019-09-01 | EXpanding Platforms for Efficacious mRNA Therapeutics | EXPERT | participant | 14.931.338 | 11 |
2017-01-01 | Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection | HIVACAR | participant | 6.685.111 | 15 |